Entrectinib for Named Patient Import

Entrectinib for Indian Patients

Entrectinib is considered to be an advanced medication used in non-small cell lung cancer treatment. It is duly approved by the US FDA and Medical Oncologists all over the world are authorized to prescribe. Apart from NSCLC, it is indicated for the treatment of Neurotrophic Tyrosine Receptor Kinase Gene Fusion Solid Tumors. This indeed makes it more promising among the new generation anti-cancer medicines. Entrectinib is a research product of Genentech and is now known by its brand name – Rozlytrek.

Entrectinib or Rozlytrek in India is not available for over the counter supplies. Being a newly approved product, it may take time for it to be registered in all the regions. Entrectinib in India may be made formally available in the due course of time. Before that, patients who may benefit from this medication can obtain the necessary permits and import the same. Rozlytrek 100mg and Rozlytrek 200mg are the commercially available strengths. Depending on the treatment plan, a formal import can be made from time to time. It is mostly the individual choice of a patient to use medicines not available in India.

Entrectinib in India? Take expert assistance.

When your Oncologist recommends Rozlytrek (Entrectinib), it could mean there are superior clinical benefits you can be hopeful about. Our expert assistance will help you in many ways. Our work is dedicated to assisting patients in order to analyze the complete requirement and plan for the procurement. We have the advantage of having access to sources that can confidently deliver Rozlytrek in India. You must be mindful about the fact that there are well defined procedures in place for your benefit. Therefore, there is absolutely no need to panic or take unnecessary stress. Be assured of end to end assistance by our team.

You can email us to nhs@noelbiotech.com or call us on + 91 9677010046 / + 919929277766.